Related Experiment Video
Updated: Jul 13, 2026
Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells
Published on: September 15, 2014
Early specification of dopaminergic phenotype during ES cell differentiation
1Institute for Stem Cell Research, University of Edinburgh, Edinburgh, UK. Malin.Parmar@med.lu.se
Background:
Understanding how lineage choices are made during embryonic stem (ES) cell differentiation is critical for harnessing strategies for controlled production of therapeutic somatic cell types for cell transplantation and pharmaceutical drug screens. The in vitro generation of dopaminergic neurons, the type of cells lost in Parkinson's disease patients' brains, requires the inductive molecules sonic hedgehog and FGF8, or an unknown stromal cell derived inducing activity (SDIA). However, the exact identity of the responding cells and the timing of inductive activity that specify a dopaminergic fate in neural stem/progenitors still remain elusive.
Results:
Using ES cells carrying a neuroepithelial cell specific vital reporter (Sox1-GFP) and FACS purification of Sox1-GFP neural progenitors, we have investigated the temporal aspect of SDIA mediated dopaminergic neuron specification during ES cell differentiation. Our results establish that SDIA induces a dopaminergic neuron fate in nascent neural stem or progenitor cells at, or prior to, Sox1 expression and does not appear to have further instructive role or neurotrophic activity during late neuronal differentiation of neural precursors. Furthermore, we show that dopaminergic neurons could be produced efficiently in a monolayer differentiation paradigm independent of SDIA activity or exogenous signalling molecules. In this case, the competence for dopaminergic neuron differentiation is also established at the level of Sox1 expression.
Conclusion:
Dopaminergic neurons are specified early during mouse ES cell differentiation. The subtype specification seems to be tightly linked with the acquisition of a pan neuroectoderm fate.
Insights
Stromal cell derived inducing activity (SDIA) specifies dopaminergic neuron fate early in embryonic stem cell (ES cell) differentiation, at or before Sox1 expression. Dopaminergic neurons can also be generated independently of SDIA.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Neuroscience
Background:
- Embryonic stem (ES) cell differentiation is crucial for generating therapeutic cell types.
- Dopaminergic neuron generation for Parkinson's disease research requires specific inductive molecules or stromal cell derived inducing activity (SDIA).
- The precise timing and responding cells for dopaminergic fate specification remain unclear.
Purpose of the Study:
- To investigate the temporal role of SDIA in dopaminergic neuron specification during ES cell differentiation.
- To identify the stage at which neural stem/progenitor cells become competent for dopaminergic fate.
- To explore alternative methods for efficient dopaminergic neuron production.
Main Methods:
- Utilized ES cells with a Sox1-GFP reporter for tracking neuroepithelial cells.
- Employed fluorescence-activated cell sorting (FACS) to purify Sox1-GFP neural progenitors.
- Investigated SDIA's effect at different stages of ES cell differentiation.
Main Results:
- SDIA induces dopaminergic neuron fate in cells at or before Sox1 expression.
- SDIA has no significant instructive or neurotrophic role in later neuronal differentiation.
- Efficient dopaminergic neuron production achieved in a monolayer culture, independent of SDIA.
- Competence for dopaminergic differentiation is established by the Sox1 expression stage.
Conclusions:
- Dopaminergic neuron specification occurs early in mouse ES cell differentiation.
- Subtype specification is closely linked to the acquisition of a general neuroectoderm fate.
- ES cell differentiation offers a viable model for studying early neuronal fate determination.
